Literature DB >> 29967335

Pharmacogenomics, a novel section in the European Journal of Human Genetics.

Henk-Jan Guchelaar1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29967335      PMCID： PMC6138632          DOI： 10.1038/s41431-018-0205-4

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN： 1018-4813            Impact factor:   4.246


× No keyword cloud information.
  15 in total

1.  Pharmacogenetics: from bench to byte.

Authors:  J J Swen; I Wilting; A L de Goede; L Grandia; H Mulder; D J Touw; A de Boer; J M H Conemans; T C G Egberts; O H Klungel; R Koopmans; J van der Weide; B Wilffert; H-J Guchelaar; V H M Deneer
Journal:  Clin Pharmacol Ther       Date:  2008-02-06       Impact factor: 6.875

2.  Concordance of DMET plus genotyping results with those of orthogonal genotyping methods.

Authors:  C A Fernandez; C Smith; W Yang; R Lorier; K R Crews; N Kornegay; J K Hicks; C F Stewart; J D Kawedia; L B Ramsey; C Liu; W E Evans; M V Relling; U Broeckel
Journal:  Clin Pharmacol Ther       Date:  2012-08-08       Impact factor: 6.875

3.  Preemptive genotyping for personalized medicine: design of the right drug, right dose, right time-using genomic data to individualize treatment protocol.

Authors:  Suzette J Bielinski; Janet E Olson; Jyotishman Pathak; Richard M Weinshilboum; Liewei Wang; Kelly J Lyke; Euijung Ryu; Paul V Targonski; Michael D Van Norstrand; Matthew A Hathcock; Paul Y Takahashi; Jennifer B McCormick; Kiley J Johnson; Karen J Maschke; Carolyn R Rohrer Vitek; Marissa S Ellingson; Eric D Wieben; Gianrico Farrugia; Jody A Morrisette; Keri J Kruckeberg; Jamie K Bruflat; Lisa M Peterson; Joseph H Blommel; Jennifer M Skierka; Matthew J Ferber; John L Black; Linnea M Baudhuin; Eric W Klee; Jason L Ross; Tamra L Veldhuizen; Cloann G Schultz; Pedro J Caraballo; Robert R Freimuth; Christopher G Chute; Iftikhar J Kullo
Journal:  Mayo Clin Proc       Date:  2014-01       Impact factor: 7.616

Review 4.  Pharmacogenetics: from bench to byte--an update of guidelines.

Authors:  J J Swen; M Nijenhuis; A de Boer; L Grandia; A H Maitland-van der Zee; H Mulder; G A P J M Rongen; R H N van Schaik; T Schalekamp; D J Touw; J van der Weide; B Wilffert; V H M Deneer; H-J Guchelaar
Journal:  Clin Pharmacol Ther       Date:  2011-03-16       Impact factor: 6.875

5.  The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.

Authors:  A R Shuldiner; M V Relling; J F Peterson; J K Hicks; R R Freimuth; W Sadee; N L Pereira; D M Roden; J A Johnson; T E Klein; Alan R Shuldiner; Mark Vesely; Shawn W Robinson; Nicholas Ambulos; Sanford A Stass; Mark D Kelemen; Lawrence A Brown; Toni I Pollin; Amber L Beitelshees; Richard Y Zhao; Ruth E Pakyz; Kathleen Palmer; Tameka Alestock; Courtney O'Neill; Kristin Maloney; Amie Branham; Danielle Sewell; Mary V Relling; Kristine Crews; James Hoffman; Shane Cross; Cyrine Haidar; Don Baker; J Kevin Hicks; Gillian Bell; Fran Greeson; Aditya Gaur; Ulrike Reiss; Alicia Huettel; Cheng Cheng; Amar Gajjar; Alberto Pappo; Scott Howard; Melissa Hudson; Ching-Hon Pui; Sima Jeha; William E Evans; Ulrich Broeckel; Russ B Altman; Li Gong; Michelle Whirl-Carrillo; Teri E Klein; Wolfgang Sadee; Kandamurugu Manickam; Kevin M Sweet; Peter J Embi; Dan Roden; Josh Peterson; Josh Denny; Jonathan Schildcrout; Erica Bowton; Jill Pulley; Marc Beller; Jennifer Mitchell; Ioana Danciu; Lisa Price; Naveen L Pereira; Richard Weinshilboum; Liewei Wang; Julie A Johnson; David Nelson; Michael Clare-Salzler; Amanda Elsey; Benjamin Burkley; Taimour Langaee; Felix Liu; David Nessl; Hui-Jia Dong; Larry Lesko; Robert R Freimuth; Christopher G Chute
Journal:  Clin Pharmacol Ther       Date:  2013-03-19       Impact factor: 6.875

Review 6.  Implementing personalized medicine: development of a cost-effective customized pharmacogenetics genotyping array.

Authors:  J A Johnson; B M Burkley; T Y Langaee; M J Clare-Salzler; T E Klein; R B Altman
Journal:  Clin Pharmacol Ther       Date:  2012-08-22       Impact factor: 6.875

Review 7.  The 1200 patients project: creating a new medical model system for clinical implementation of pharmacogenomics.

Authors:  P H O'Donnell; A Bush; J Spitz; K Danahey; D Saner; S Das; N J Cox; M J Ratain
Journal:  Clin Pharmacol Ther       Date:  2012-08-29       Impact factor: 6.875

8.  Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.

Authors:  C H van der Wouden; A Cambon-Thomsen; E Cecchin; K C Cheung; C L Dávila-Fajardo; V H Deneer; V Dolžan; M Ingelman-Sundberg; S Jönsson; M O Karlsson; M Kriek; C Mitropoulou; G P Patrinos; M Pirmohamed; M Samwald; E Schaeffeler; M Schwab; D Steinberger; J Stingl; G Sunder-Plassmann; G Toffoli; R M Turner; M H van Rhenen; J J Swen; H-J Guchelaar
Journal:  Clin Pharmacol Ther       Date:  2017-03       Impact factor: 6.875

9.  Development and use of active clinical decision support for preemptive pharmacogenomics.

Authors:  Gillian C Bell; Kristine R Crews; Mark R Wilkinson; Cyrine E Haidar; J Kevin Hicks; Donald K Baker; Nancy M Kornegay; Wenjian Yang; Shane J Cross; Scott C Howard; Robert R Freimuth; William E Evans; Ulrich Broeckel; Mary V Relling; James M Hoffman
Journal:  J Am Med Inform Assoc       Date:  2013-08-26       Impact factor: 4.497

10.  Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process.

Authors:  Kelly E Caudle; Teri E Klein; James M Hoffman; Daniel J Muller; Michelle Whirl-Carrillo; Li Gong; Ellen M McDonagh; Katrin Sangkuhl; Caroline F Thorn; Matthias Schwab; Jose A G Agundez; Robert R Freimuth; Vojtech Huser; Ming Ta Michael Lee; Otito F Iwuchukwu; Kristine R Crews; Stuart A Scott; Mia Wadelius; Jesse J Swen; Rachel F Tyndale; C Michael Stein; Dan Roden; Mary V Relling; Marc S Williams; Samuel G Johnson
Journal:  Curr Drug Metab       Date:  2014-02       Impact factor: 3.731
View more
  1 in total

1.  Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone).

Authors:  Maja Matic; Marga Nijenhuis; Bianca Soree; Nienke J de Boer-Veger; Anne-Marie Buunk; Elisa J F Houwink; Hans Mulder; Gerard A P J M Rongen; Jan van der Weide; Bob Wilffert; Jesse J Swen; Henk-Jan Guchelaar; Vera H M Deneer; Ron H N van Schaik
Journal:  Eur J Hum Genet       Date:  2021-07-15       Impact factor: 5.351
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.